A recent study measured the expression of VLA-4 and CXCR4 in BM aspirates of 98 patients with newly diagnosed AML, and proved that the level of VLA-4 was higher in patients that belong to favorable and intermediate risk classes. This evidence concerns the gene CXCR4 and acute myeloid leukemia.